Given Imaging Ltd., the global leader in patient-friendly GI diagnostic and monitoring solutions, today announced three new studies that demonstrate the clinical utility of PillCam SB capsule endoscopy in providing physicians with critical information on how they manage and/or diagnose intestinal disorders. These novel studies were carried out in pediatric patients with gastrointestinal symptoms ...
Posted by Vyvanse In the News on at
Filed under Vyvanse News · Tagged with Capsule Endoscopy, Gastrointestinal, Gastrointestinal Symptoms, Given Imaging Ltd, Global Leader, Intestinal Disorders, Medical Imaging, Monitoring Solutions, Novel Studies, Pediatric Patients, Physicians, Today Announced Three
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ABILIFY® (aripiprazole) for the treatment of irritability associated with autistic disorder in pediatric patients ages 6 to 17 years, including symptoms of aggression towards others, deliberate self ...
Posted by Vyvanse In the News on at
Filed under Vyvanse News · Tagged with 17 Years, Abilify, Aggression, Aripiprazole, Autism, Autistic Disorder, Bristol Myers, Bristol Myers Squibb, Bristol Myers Squibb Company, Drug Application, Fda, Fda Approved, Food And Drug, Food And Drug Administration, Food And Drug Administration Fda, Irritability, Myers Squibb Company, Otsuka Pharmaceutical Co, Pediatric Patients, Snda
